Biotech: Pressemitteilungen - Kategorie - Seite 19

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Aevi Genomic Medicine Announces Enrollment of First Patient in Phase 1/2 Clinical Trial of AEVI-001 in 22q Deletion Syndrome

PHILADELPHIA, PA: PHILADELPHIA, PA -- (Marketwired) -- 01/31/17 -- (NASDAQ: GNMX) (the Company) announced today that the first patient has been dosed in a Phase 1/2 clinical trial to assess the efficacy of its lead i ...

Trillium Therapeutics Doses First Patient With TTI-621 in Phase 1 Solid Tumor Trial

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 01/31/17 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TR), a clinical-stage immuno-oncology company developing innovative therapies for the treatment of canc ...

Lattice Biologics Ltd. Reports Fourth Quarter and Year End 2016 Highlights

SCOTTSDALE, ARIZONA: New core product sales increase 147% fourth quarter over fourth quarter ...

Corcept Therapeutics Announces Preliminary Fourth Quarter and Full-Year 2016 Financial Results and Corporate Update; Provides 2017 Revenue Guidance

MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 01/30/17 -- Corcept Therapeutics Incorporated (NASDAQ: CORT)Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, dev ...

CORRECTION FROM SOURCE: Calyx Provides Corporate Update

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/30/17 -- This document corrects and replaces the press release that was sent today at 8:00 am ET. The embedded URL was changed.Calyx Bio-Ventures In ...

Calyx Provides Corporate Update

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/30/17 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) ("Calyx" or the "Company") is pleased to provide an update on its ongoing b ...

Court Schedules Hearing To Consider Approval Of Settlement Of Derivative Action

NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 01/27/17 -- iBio, Inc. (NYSE MKT: IBIO) On January 20, 2017, the Supreme Court for the State of New York, County of New York, scheduled a hearing to consider approval ...

Cellestia Biotech AG: Cellestia Biotech raises CHF 8M seed financing

BASEL, SWITZERLAND: BASEL, SWITZERLAND -- (Marketwired) -- 01/26/17 -- Cellestia Biotech AG -Basel, Switzerland - January 26, 2017 - Cellestia Biotech AG, a private biopharmaceutical company with strategic focus on anti ...

ANGLE plc: Positive Interim Evaluation of Ovarian Cancer Clinical Studies

GUILDFORD, UNITED KINGDOM: GUILDFORD, UNITED KINGDOM -- (Marketwired) -- 01/26/17 -- Angle PLC (AIM: AGL) (OTCQX: ANPCY)AIM:AGL OTCQX:ANPCYPatient enrolment European study now over 90% complete and US study 70% complete; Headl ...

Acquisition and Disposition of Securities of Hemostemix Inc.

CALGARY, ALBERTA: CALGARY, ALBERTA -- (Marketwired) -- 01/25/17 -- Wood Capital Ltd. ("Wood Capital") an entity controlled by Blake Wood, acquired a CDN$1,000,000 convertible debenture (the "Debenture& ...

Acquisition and Disposition of Securities of Hemostemix Inc.

CALGARY, ALBERTA: CALGARY, ALBERTA -- (Marketwired) -- 01/25/17 -- Drive Capital Corp. ("Drive Capital") an entity controlled by Jed M. Wood, acquired a CDN$1,000,000 convertible debenture (the "Debent ...

Aldeyra Therapeutics Announces Clinical Development Update for Phase 3 Programs

LEXINGTON, MA: LEXINGTON, MA -- (Marketwired) -- 01/25/17 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX)Noninfectious Anterior Uveitis: Enrollment of first-ever vehicle-controlled Phase 3 clinical trial is expected t ...

SHYFT Analytics Appoints Joseph Tyers to Chief Revenue Officer

WALTHAM, MA: Life Sciences Software Executive to Lead Commercial Team ...

Prima BioMed to Present at 2nd Annual Cancer Immunotherapy Conference

SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 01/22/17 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima" or the "Company") announces that the submission titled "TACTI-mel, Two A ...

Prima BioMed Commences Randomised Phase IIb Clinical Trial for IMP321 in Breast Cancer

SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 01/19/17 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima" or the "Company") today announced the first patient has been dosed as part of ...

Prima BioMed to Maintain NASDAQ Listing

SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 01/18/17 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) the "Company" has received notification from the Listing Qualifications Department of the NASDAQ ...

Theratechnologies Inc.: Ibalizumab 24-Week Pivotal Phase III Study Results Accepted as a Late Breaker Will Be Presented at CROI 2017

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 01/17/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) announces that the abstract submitted by its partner, TaiMed Biologics, Inc., for the 24-week st ...

Beyond the Smoke Stacks: Texas Ropes in $4 Billion Pharma-Bio Investment, an Industrial Info News Alert

SUGAR LAND, TX: SUGAR LAND, TX -- (Marketwired) -- 01/17/17 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- When many people hear the word "Texas," it evokes a number of cl ...

SpeeDx and UgenTec launch FastFinder for ResistancePlus MG Test

SYDNEY, AUSTRALIA and HASSELT, BELGIUM: Artificially intelligent interpretation module automatically incorporates test results into lab information systems ...

Valens GroWorks Licensing Inspection Completed

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/13/17 -- Valens GroWorks Corp. (CSE: VGW)(CSE: VGW.CN)(the "Company") is pleased to announce the completion, by the Regional Inspectorate ...


Seite 19 von 255:  « ..  18 19 20  21  22  23  24  25  26  27  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z